Cargando…

The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients

CONTEXT: Autoantibodies have a role in the diagnosis and prognosis in Autoimmune Inflammatory Myositis (AIM). AIMS: The aim of this work was to study the prevalence and clinical correlation of myositis specific and associated antibodies (MSA and MAA) in AIM. SETTING AND DESIGN: This was a cross-sect...

Descripción completa

Detalles Bibliográficos
Autores principales: Negalur, Natasha Vijay, Ekbote, Gayatri G., Raval, Dhiren N., Tanna, Dhaval V., Kazi, Wasim S., Bindroo, Muzaffar A., Yadavalli, Durgarao J., Gupta, Rajiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513958/
https://www.ncbi.nlm.nih.gov/pubmed/34728950
http://dx.doi.org/10.4103/aian.AIAN_1151_20
_version_ 1784583302033702912
author Negalur, Natasha Vijay
Ekbote, Gayatri G.
Raval, Dhiren N.
Tanna, Dhaval V.
Kazi, Wasim S.
Bindroo, Muzaffar A.
Yadavalli, Durgarao J.
Gupta, Rajiva
author_facet Negalur, Natasha Vijay
Ekbote, Gayatri G.
Raval, Dhiren N.
Tanna, Dhaval V.
Kazi, Wasim S.
Bindroo, Muzaffar A.
Yadavalli, Durgarao J.
Gupta, Rajiva
author_sort Negalur, Natasha Vijay
collection PubMed
description CONTEXT: Autoantibodies have a role in the diagnosis and prognosis in Autoimmune Inflammatory Myositis (AIM). AIMS: The aim of this work was to study the prevalence and clinical correlation of myositis specific and associated antibodies (MSA and MAA) in AIM. SETTING AND DESIGN: This was a cross-sectional observational study. METHODS AND MATERIALS: Consecutive AIM patents were divided into groups as dermatomyositis (DM), polymyositis (PM), CTD-associated myositis (CTD-M), cancer-associated myositis (CAM) and juvenile myositis (JM). Their data along with serum samples were collected after obtaining informed consent. Sera was analyzed for IgG antibodies against Jo-1, PL-7, PL-12, EJ, SRP, Mi-2, MDA-5, TIF1γ, SAE1, SAE2, NXP2 and SSA/R052kD using the microELISA technique. The institutional ethics committee approved the study. STATISTICAL ANALYSIS: SPSS software (version 24.0) was used. P value < 0.05 was considered statistically significant. RESULTS: There were 48 patients (DM = 19, PM = 19, CTD-M = 5, CAM = 2, JM = 3) included. MSA were positive in 37.5% patients. Antibodies against Mi-2 were present in 6 (12.5%), Jo-1 in 5 (10.4%), 2 (4.1%) each had PL-7 and SRP antibodies. One patient (2%) each had MDA-5, NXP2 and TIf1g antibodies. Jo-1 antibody was associated with mechanic's hands and ILD. There was a significant association of rash in the Mi-2 group with none of the patients having ILD. Malignancy screening was negative in NXP2 and TIF1g antibody-positive patients. Ro52 was the most common MAA (33.3%) and was associated with mechanic's hand. CONCLUSION: MSA was present in almost 40% of the cohort. Anti Jo-1 antibody was associated with mechanic's hands and ILD. None of the Mi-2 patients had ILD, which may point to a protective role of this antibody for ILD. The association of newer antibodies in Indian patients needs to be further studied in larger cohorts.
format Online
Article
Text
id pubmed-8513958
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-85139582021-11-01 The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients Negalur, Natasha Vijay Ekbote, Gayatri G. Raval, Dhiren N. Tanna, Dhaval V. Kazi, Wasim S. Bindroo, Muzaffar A. Yadavalli, Durgarao J. Gupta, Rajiva Ann Indian Acad Neurol Original Article CONTEXT: Autoantibodies have a role in the diagnosis and prognosis in Autoimmune Inflammatory Myositis (AIM). AIMS: The aim of this work was to study the prevalence and clinical correlation of myositis specific and associated antibodies (MSA and MAA) in AIM. SETTING AND DESIGN: This was a cross-sectional observational study. METHODS AND MATERIALS: Consecutive AIM patents were divided into groups as dermatomyositis (DM), polymyositis (PM), CTD-associated myositis (CTD-M), cancer-associated myositis (CAM) and juvenile myositis (JM). Their data along with serum samples were collected after obtaining informed consent. Sera was analyzed for IgG antibodies against Jo-1, PL-7, PL-12, EJ, SRP, Mi-2, MDA-5, TIF1γ, SAE1, SAE2, NXP2 and SSA/R052kD using the microELISA technique. The institutional ethics committee approved the study. STATISTICAL ANALYSIS: SPSS software (version 24.0) was used. P value < 0.05 was considered statistically significant. RESULTS: There were 48 patients (DM = 19, PM = 19, CTD-M = 5, CAM = 2, JM = 3) included. MSA were positive in 37.5% patients. Antibodies against Mi-2 were present in 6 (12.5%), Jo-1 in 5 (10.4%), 2 (4.1%) each had PL-7 and SRP antibodies. One patient (2%) each had MDA-5, NXP2 and TIf1g antibodies. Jo-1 antibody was associated with mechanic's hands and ILD. There was a significant association of rash in the Mi-2 group with none of the patients having ILD. Malignancy screening was negative in NXP2 and TIF1g antibody-positive patients. Ro52 was the most common MAA (33.3%) and was associated with mechanic's hand. CONCLUSION: MSA was present in almost 40% of the cohort. Anti Jo-1 antibody was associated with mechanic's hands and ILD. None of the Mi-2 patients had ILD, which may point to a protective role of this antibody for ILD. The association of newer antibodies in Indian patients needs to be further studied in larger cohorts. Wolters Kluwer - Medknow 2021 2021-05-21 /pmc/articles/PMC8513958/ /pubmed/34728950 http://dx.doi.org/10.4103/aian.AIAN_1151_20 Text en Copyright: © 2006 - 2021 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Negalur, Natasha Vijay
Ekbote, Gayatri G.
Raval, Dhiren N.
Tanna, Dhaval V.
Kazi, Wasim S.
Bindroo, Muzaffar A.
Yadavalli, Durgarao J.
Gupta, Rajiva
The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients
title The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients
title_full The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients
title_fullStr The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients
title_full_unstemmed The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients
title_short The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients
title_sort association of myositis specific antibodies in patients with inflammatory myositis: preliminary data in indian patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513958/
https://www.ncbi.nlm.nih.gov/pubmed/34728950
http://dx.doi.org/10.4103/aian.AIAN_1151_20
work_keys_str_mv AT negalurnatashavijay theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT ekbotegayatrig theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT ravaldhirenn theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT tannadhavalv theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT kaziwasims theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT bindroomuzaffara theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT yadavallidurgaraoj theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT guptarajiva theassociationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT negalurnatashavijay associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT ekbotegayatrig associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT ravaldhirenn associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT tannadhavalv associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT kaziwasims associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT bindroomuzaffara associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT yadavallidurgaraoj associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients
AT guptarajiva associationofmyositisspecificantibodiesinpatientswithinflammatorymyositispreliminarydatainindianpatients